ICD-10 Code H22: Disorders of iris and ciliary body

Key Takeaways

H22 is a non-billable ICD-10-CM header code for disorders of the iris and ciliary body caused by a separately classified underlying disease.

A mandatory ‘Code First’ instruction applies: the underlying etiology (e.g. sarcoidosis, syphilis) must be sequenced before H22.0 or H22.1 on every claim.

H22 itself cannot be submitted for reimbursement; use H22.0 for infectious/parasitic etiologies or H22.1 for all other underlying conditions.

Pabau’s claims management software supports multi-code sequencing and documentation workflows for ophthalmology and general practices managing secondary eye diagnoses.

ICD-10 Code H22 identifies Disorders of iris and ciliary body in diseases classified elsewhere. It sits within the ICD-10-CM block H15-H22 (Disorders of sclera, cornea, iris and ciliary body), which itself falls under chapter H00-H59 (Diseases of the eye and adnexa).

The same block also covers corneal and sclera codes such as H17.9 (unspecified corneal scar and opacity) and H18.10 (bullous keratopathy, unspecified eye).

According to the WHO ICD-10 browser, H22 captures ocular manifestations that arise secondary to a systemic disease already coded elsewhere in the classification.

The iris and ciliary body together form the anterior uveal tract. When an underlying systemic condition (infectious, inflammatory, or metabolic) triggers inflammation or structural disruption in this region, the resulting iridocyclitis is coded as a manifestation rather than a primary diagnosis. That distinction drives the entire coding workflow for H22.

What iridocyclitis means clinically

Iridocyclitis is inflammation of both the iris and the ciliary body simultaneously. Clinically, it presents as anterior uveitis: pain, photophobia, reduced visual acuity, ciliary flush, and anterior chamber exudates (cells and flare on slit-lamp). When these findings are caused by an identifiable systemic disease rather than arising spontaneously, H22 codes apply rather than the primary H20 iridocyclitis codes.

The diagnostic workup in these cases focuses on identifying the underlying condition. That underlying condition is what drives code selection before H22.0 or H22.1 ever appears on the claim. For a deeper look at how Pabau supports claims management software for multi-diagnosis ophthalmology encounters, the feature page walks through the sequencing workflow in detail.

H22 subcodes: H22.0 and H22.1 explained

ICD-10 Code H22 is a non-billable header. You cannot submit H22 alone for reimbursement. The two billable subcodes beneath it are H22.0 and H22.1, and the distinction between them turns entirely on the nature of the underlying disease.

H22.0: Infectious and parasitic etiologies

H22.0 applies when the underlying cause is an infectious or parasitic disease. Common etiologies include:

• Syphilis (A51, A52 series): secondary or tertiary syphilitic iridocyclitis
• Herpes zoster (B02 series): zoster-associated anterior uveitis, often unilateral with sectoral iris atrophy
• Tuberculosis (A18.54): granulomatous anterior uveitis in ocular TB
• Toxoplasmosis (B58.01): chorioretinitis with anterior segment spillover
• Leprosy (A30 series): chronic anterior uveitis in multibacillary leprosy

The infectious disease code is always sequenced first. H22.0 follows as the manifestation.

H22.1: Non-infectious systemic etiologies

H22.1 covers iridocyclitis arising from non-infectious systemic conditions. The etiology is still classified elsewhere in ICD-10-CM, but it falls outside the infectious disease chapters. Common examples include:

• Ankylosing spondylitis (M45 series): HLA-B27-associated recurrent anterior uveitis
• Sarcoidosis (D86 series): granulomatous anterior uveitis, often bilateral
• Behcet disease (M35.2): recurrent hypopyon uveitis with severe visual risk
• Rheumatoid arthritis (M05, M06 series): juvenile or adult RA-associated iridocyclitis
• Psoriatic arthritis (L40.5 series): spondyloarthropathy-related anterior uveitis

For practices managing these patients, thorough patient record documentation of the systemic diagnosis is what validates the H22.1 manifestation code at audit. A vague note referencing “underlying rheumatologic condition” will not satisfy payer medical necessity review.

Code First instruction: How etiology-manifestation sequencing works with ICD-10 Code H22

The tabular note for ICD-10 Code H22 carries a mandatory “Code First” instruction. This is not advisory. It is a binding sequencing rule enforced by CMS and documented in the CMS ICD-10-CM coding guidelines.

Under the etiology-manifestation convention, certain conditions have both an underlying cause and a body-system manifestation resulting from that cause. When this applies, ICD-10-CM instructs coders to sequence the etiology code first and the manifestation code second. H22.0 and H22.1 are both manifestation codes. They cannot appear as the principal diagnosis.

Sequencing example: Ankylosing spondylitis with iridocyclitis

A rheumatology practice sees a patient with established ankylosing spondylitis who presents with acute anterior uveitis. The correct code sequence is:

1. M45.0 (or appropriate M45 subcode): Ankylosing spondylitis of multiple sites in spine (principal/first-listed)
2. H22.1: Iridocyclitis in other diseases classified elsewhere (manifestation, sequenced second)

Reversing this sequence (H22.1 first, M45 second) will result in a claim edit or denial from most payers. The M45 code should reflect the documented spinal region, such as M45.2 for cervical involvement.

Sequencing example: Herpes zoster with anterior uveitis

An ophthalmologist documents herpes zoster ophthalmicus with iridocyclitis. The correct sequence is:

1. B02.32: Zoster iridocyclitis (note: this specific subcode in the B02 category already captures zoster-induced iridocyclitis and may be used alone; consult your encoder for the encounter-specific instruction)
2. H22.0: Iridocyclitis in infectious and parasitic diseases classified elsewhere (if the encoder requires the manifestation code)

Some encoders and payer systems will accept B02.32 as a standalone billable code without requiring H22.0. Verify your encoder’s logic and payer-specific guidance before submission.

Documentation requirements for H22 coding

Payer audits for H22 claims almost always focus on one thing: does the medical record support both the manifestation diagnosis and the underlying systemic disease? Missing documentation at either level creates recoupment risk.

For H22.0 or H22.1 to withstand audit, the clinical note must include:

• An explicit diagnosis of the underlying systemic condition (not just “history of” or “rule out”)
• Clinical findings consistent with anterior uveitis or iridocyclitis (slit-lamp findings, visual acuity, anterior chamber assessment)
• A documented link between the systemic disease and the ocular manifestation (e.g. “anterior uveitis in the context of known HLA-B27-positive ankylosing spondylitis”)
• The treating clinician’s name and credentials, confirming the systemic diagnosis is established rather than suspected

Using digital intake forms to capture systemic disease history at the point of check-in helps ensure this background is consistently recorded before the encounter note is written. Missing systemic history is one of the most preventable causes of H22 claim denials.

The exam itself should reflect a billable encounter such as CPT 92002 (intermediate eye exam for new patients), supported by structured findings captured on a template like the PERRLA eye exam form.

Streamline multi-code claims for ophthalmology

Pabau helps ophthalmology and general practices document etiology-manifestation pairs, manage structured clinical notes, and submit accurate multi-code claims from a single workflow.

Book a demo

Related codes and crosswalks for ICD-10 Code H22

Understanding where H22 sits within the broader iridocyclitis coding landscape helps coders choose the right code on first pass. The primary distinction is between iridocyclitis that arises on its own (coded under H20) and iridocyclitis that arises as a manifestation of a classified systemic disease (coded under H22).

When the underlying systemic condition is known and documented, always prefer H22.0 or H22.1 over the unspecified H20 codes. Specificity directly supports medical necessity documentation and reduces the likelihood of a payer downgrading or denying the encounter.

The same “in diseases classified elsewhere” pattern appears elsewhere in the H00-H59 chapter, such as H42 (glaucoma in diseases classified elsewhere), which follows an identical Code First sequencing rule. That differs from disorders confined to a single structure with no etiology-manifestation requirement, such as H02.9 (unspecified disorder of eyelid) or H25.9 (unspecified age-related cataract).

Coders working across the broader eye chapter also encounter standalone codes such as H35.9 (unspecified retinal disorder), H01.9 (unspecified inflammation of eyelid), and H16.8 (other keratitis) — none of which carry the Code First requirement that defines H22.

For practices that need to cross-reference procedure codes alongside these diagnostic codes, the AAPC Codify ICD-10-CM lookup provides a searchable crosswalk. For EHR integration workflows that map diagnostic codes to procedure codes at the point of documentation, a structured EHR reduces manual crosswalk errors. See also Pabau’s EHR integration workflows for how diagnostic code data flows into billing records automatically.

Billing workflow and payer considerations for H22

H22 claims typically appear in two practice settings: ophthalmology (where the eye findings are the presenting complaint) and internal medicine or rheumatology (where the systemic disease is the primary focus and the eye is a monitored organ system). Each setting has a slightly different workflow risk.

In ophthalmology, the risk is submitting H22.0 or H22.1 without the etiology code because the referring note from another specialty confirmed the systemic diagnosis but the ophthalmology EHR only captured the eye finding.

In rheumatology or infectious disease, the risk is the opposite: the systemic code is submitted correctly but the eye manifestation code is omitted, losing the documentation of disease-related organ involvement.

Common denial patterns for H22 claims

Based on the ICD-10-CM coding convention requirements, these are the most frequent reasons H22-related claims are rejected or denied:

• Missing etiology code: H22.0 or H22.1 submitted without the underlying disease code in the first position
• Reversed sequencing: H22.x in the first position with the etiology code in a secondary position
• Using H22 (header) as a billable code: The parent code H22 submitted instead of H22.0 or H22.1
• Insufficient documentation: No explicit systemic diagnosis in the clinical note to support the Code First instruction
• Mismatch between etiology and subcode: A non-infectious systemic condition (e.g. sarcoidosis) paired with H22.0 instead of H22.1

Using AI-powered clinical documentation to auto-structure encounter notes helps flag when a systemic diagnosis mentioned in the note has not been mapped to the corresponding manifestation code. This reduces the mismatch between what the clinician documented and what the coder sees.

For practices building out HIPAA-compliant practice documentation workflows, structured note templates also make the etiology-manifestation relationship explicit in the record.

Payer-specific considerations

Medicare processes H22.x claims through its standard ICD-10-CM claim adjudication logic. The CDC/NCHS ICD-10-CM coding tool confirms the current valid status of H22.0 and H22.1 for each fiscal year.

Commercial payers generally follow the same sequencing rules as CMS but may have local coverage determinations (LCDs) that specify additional documentation for specific underlying conditions (particularly sarcoidosis and Behcet disease, both of which require specialist-confirmed diagnoses in many plans).

Using practice management software that integrates diagnostic coding with billing workflows ensures the Code First pairing is enforced before a claim leaves the practice, not after a denial forces a rework cycle.

Conclusion

The most expensive mistake with ICD-10 Code H22 is a sequencing error that turns a clean claim into a denial. The Code First rule is unambiguous: the etiology goes first, the manifestation follows. H22.0 belongs with infectious etiologies, H22.1 with non-infectious systemic conditions, and the parent H22 code is never submitted alone.

Pabau’s skin clinic software and broader practice management platform support structured documentation that captures the systemic diagnosis and the ocular manifestation in a single linked workflow, reducing coding errors at the source. If your practice manages patients with complex systemic conditions that affect the eye, book a demo and see how Pabau handles this.

Continue your research

Need structured clinical notes for complex multi-system diagnoses? Psychiatric Evaluation Template shows how structured templates capture systemic disease history alongside presenting complaint documentation.

Managing compliance documentation for diagnostic coding? Medical spa compliance checklist outlines the documentation standards that apply to clinical records supporting secondary diagnosis codes.

Frequently asked questions